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                                                              ABSTRACT 
Adverse effects and increasing cost of therapeutic drugs have renewed an interest in the use of 
medicinal plant products for the treatment of a variety of chronic disorders. One such bioactive 
plant-derived compound is a pentacyclic triterpenoid, oleanolic acid (3ß-hydroxy-olea-12-en-28-
oic acid, OA) present in herbs. OA possesses a variety of pharmaceutical activities and of 
interest in this study are the anti-diabetic properties. Diabetes is associated with disorders 
grouped as microvascular (retinopathy and nephropathy) and macrovascular (atherosclerotic) 
complications. Accordingly, this study further investigated the potential of OA in diabetes 
management by studying the effects of this triterpene on kidney function as well as proximal 
tubular Na+ handling in an effort to identify the site of action of OA. Furthermore, the study 
evaluated the effects of OA in kidney and liver cell lines to establish whether this triterpene 
exhibits any toxicity in these organs. 
 
OA was extracted using a previously validated protocol in our laboratory. Briefly, dried flower 
buds of Syzygium aromaticum were soaked in dichloromethane overnight, thereafter in ethyl acetate to 
obtain ethyl acetate solubles which contained a mixture of OA/ursolic and maslinic acid (MA). OA/MA 
mixture was subjected to column chromatograph and pure OA was obtained through recrystallization in 
methanol. The absolute stereostructure of OA was elucidated using 1H and 13C NMR spectroscopy and 
was comparable to previously reported data. In kidney function studies, various doses of OA (30, 60, 
120 mg/kg, p.o.) were administered to male Sprague-Dawley rats twice (8h apart) every third day 
for five weeks. Rats administered deionised water served as controls. Measurements of body 
weight, food and water intake, blood pressure, Na+, K+, Cl-, urea and creatinine were taken 24 h 
from dosing. Renal clearance studies investigated the influence of OA on Na+ handling in the 
proximal tubule of anaesthetized rats using lithium clearance. Animals were given water with 
lithium (12mmol/l) for 48 hours following which they were anaesthetized and cannulated using a 
previously validated standard protocol that has been reported from our laboratories. After a 3½ h 
equilibration, animals were challenged with hypotonic saline for 4 h of 1 h control, 1½ h 
treatment and 1½ h recovery periods. OA was added to the infusate during the treatment period. 
In vitro effects of various OA concentrations (5, 10, 20, 40, 80 µmol/l) were investigated in 
HEK293, MDBK and HepG2cell lines. Cells were exposed to OA for 24, 48 and 72 h, thereafter, 
xix 
 
3-4,5 dimethylthiazol-2-yl- 2,5diphenyltetrozolium bromide (MTT) and single cell gel 
electrophoresis (comet) assays were conducted. All data are presented as means ±SEM.  
 
OA significantly (p<0.05) increased urinary Na+ output from week 2 until the end of the 
experimental period in a dose independent manner. However, this OA-evoked natriuresis was not 
reflected in plasma collected at the end of the experiment as there was no change in plasma Na+ 
concentrations compared with control animals at the corresponding time. OA administration had 
no significant influence on K+ and Cl- excretion rates throughout the experiment. However, OA 
significantly (p<0.05) reduced plasma creatinine concentration with a concomitant increase in 
glomerular filtration rate (GFR). Furthermore, OA administration significantly (p<0.05) 
decreased mean arterial pressure from week 2 until the end of the experimental period. 
Intravenous infusion of OA at 90 ug/h for 1 ½ h induced a marked increase in urinary excretion 
rates of Na+. This increase was accompanied by concomitant increase in FENa proximal and FENa 
distal and FELi which persisted until the end of the experiment without any apparent changes in 
GFR. The cell viabilities of HepG2, HEK293 and MDBK cell lines were significantly increased 
after 24 h exposure, however, the viabilities of all the three cell lines dropped after 72 h exposure 
to values that did not achieve statistical significance in comparison to the respective controls. In 
addition, all OA-treated cells in the comet assay had intact DNA after exposure for 24, 48 and 72 
h. Hence, the decrease in viability that was observed in the MTT assay after 72 h exposure could 
probably be attributed to the depletion of nutrients in the culture medium. 
 
The results of the present study, apart from confirming our previous observations of the 
natriuretic effects of OA in rats, indicate that this effect is in part mediated via the inhibition of 
proximal tubular Na+ reabsorption and increased Na+ secretion. We speculate that this increased 
Na+ secretion could have been due to increased tubular function and not to the toxicity of OA as 
indicated by MTT and comet assays. These findings suggest that OA does not exhibit toxicity in 




                                                               CHAPTER 1 




In recent years, there has been a renewed interest in the use of plant products for the treatment 
of a variety of chronic disorders. One such bioactive plant-derived compound is a pentacyclic 
triterpenoid, oleanolic acid (3ß-hydroxy-olea-12-en-28-oic acid, OA) present in herbs and 
dietary plants. OA possesses a variety of medicinal claims which include anti-inflammatory, 
anti-cancer, anti-stomach ulcer, anti-hyperlipidaemic, anti-hypertensive, cardiotonic, anti-
dysrhythmic, anti-aggregation of blood platelets, hepato-protective and anti-diabetic effects. Of 
interest in our laboratory are the anti-diabetic properties of OA. Diabetes mellitus is 
characterized by hyperglycaemia which compromises kidney function. Reports indicate that the 
majority of morbidity and mortality in diabetes is caused by end stage renal disease (ESRD). 
Therefore, this study investigated the effects of OA proximal tubular Na+ handling. In addition, 
we evaluated the effects of OA in human embryonic kidney (HEK293) and Madin-Darby 
bovine kidney (MDBK) cell lines to establish whether OA has any toxic effects on the kidney. 
Furthermore, we evaluated the effects of OA in hepatocyte-derived human transformed 
(HepG2) cell lines since the liver is responsible for biotransformation of drugs. Chapter 1 
describes the physiology of kidney function, adverse effects of diabetes, particularly on renal 
haemodynamics and kidney cell structure and how drugs can influence these adverse effects, 
















1.1.1. Kidney function 
Kidneys play a vital role in maintaining the normal volume and composition of body fluids 
DeFronzo, Davidson and Prato, 2011; Rosner and Bolton, 2006; Zhu and Wang, 2008; 
Edwards, 2010). They achieve this by working together with other body organs like the lungs 
and the liver to ensure that homeostasis is maintained. The kidneys maintain this homeostasis 
through filtration, reabsorption and secretion (DeFronzo et al., 2011; Wagner, Kovacikova, 
Stehberger, Winter, Benabbas and Mohebbi, 2006). Tubular reabsorption of electrolytes and 
water is regulated by hormones and physical factors such as renal arterial pressure and 
glomerular filtration rate (GFR) (Rosner and Bolton, 2006; Edwards, 2010). However, in 
adverse conditions like diabetes mellitus, regulation of tubular reabsorption of electrolytes is 
disrupted due to structural and functional changes of the kidney caused by hyperglycaemia 
thereby resulting in the decline of renal function. This study focused on the potential of OA to 
avert the decline in renal function. 
 
1.1.2. Kidney structural and functional relationship 
The kidney is made up of the outer cortex and the inner medulla regions (Gloviczki, Glockner, 
Gomez, Romero, Lerman, McKusick and Textor, 2009; Dyson, Bezemer, Legrand, Balestra, 
Singer and Ince, 2011). The medulla has pyramids which have an apex that extend towards 
the renal pelvis to form a papilla. These renal pyramids have striations which appear to be the 
straight loop of Henle, collecting ducts and blood vessels (Moffat and Fourman, 1963; Yuan 
and Pannabecker, 2010). The basic functional unit of the kidney is a nephron (Prasad, Narra, 
Shah, Humphrey, Jagirdar, Catena, Dalrymple and Siegel, 2007) which is a thin tube with a 
blind glomerulus end and an open collecting duct end.  The nephron is made up of a renal 
corpuscle and renal tubule; different sections of this structure are responsible for secretion and 





In the human kidney, approximately 180 litres of plasma containing sodium chloride, sodium 
bicarbonate, glucose and many other solutes are filtered through the renal corpuscle each day 
(DeFronzo et al., 2011; Wright, Hirayama and Loo, 2007; Abdul-Ghani and DeFronzo, 2008).  
The kidney renal corpuscle comprises of the glomerulus surrounded by the Bowman’s capsule 
which have specialized epithelial cells called podocytes (Prasad et al., 2007; Navar, 2009). 
Podocytes, basement membrane and the endothelial cells form a filtration barrier which is 
semi-permeable to molecules entering the renal tubule (Neal, Muston, Njegovan, Verrill, 
Harper, Deen and Bates, 2007; Navar, 2009). However, the function of this glomerular 
filtration barrier becomes abnormal in diabetes due to glomerular hypertrophy, thickening of 
glomerular basement membrane and injury of the podocytes (Susztak, Raff, Schiffer and 
Böttinger, 2006). Other cells that line the renal corpuscle are juxtaglomerular apparatus 
composed of vascular smooth muscle cells, endothelial cells, mesangial cells, macula densa 
cells, and renin-secreting juxtaglomerular granular cells (Yao, Oite and Kitamura, 2009). The 
morphology of these kidney cells is altered due to injury caused by various substances which 
are products of hyperglycaemia. Accordingly, this study investigated the effects of OA on the 
viability and DNA intergrity of isolated kidney cell lines to relate to in vivo effects of OA. In 
addition, the study investigated the effects of OA in liver cells since they play a vital role in 
the degradation of drugs.  
 
The sequel of events in diabetes results in overproduction of nitric oxide (NO) which cause 
persistent vasodilation of the afferent and efferent arterioles which cause hyperfiltration 
(Tolins, Shultz, Raij, Brown and Mauer, 1993; Komers, Lindsley, Oyama, Allison and 
Anderson, 2000). Hyperfiltration increases the load of Na+ delivered to the macula densa 
cells. Stimulation of the macula densa cells results in an enhanced tubulo-glomerular feedback 
mechanism that causes hyperactivation of the renin-angiotensin-aldosterone system (RAAS) 
which increases Na+ reabsorption (Bickel, Knepper, Verbalis and Ecelbarger, 2002; Raij, 
2005; Zerbini, Bonfanti, Meschi, Bognetti, Paesano, Gianolli, Querques, Maestroni, Calori, 
Maschio, Fazio, Luzi and Chiumello, 2006). This hyperfiltration may be reversed by synthetic 
drugs like L-arginine derivatives which inhibit NO synthesis resulting in increased renal 




addition, bioactive compounds isolated from various medicinal plants like triptolide from 
Tripterygium wilfordii, tetrandrine and related alkaloids from Tetrandra Stephenia, 
higenamine from Aconittum coreanum, tetramethyl pyrazine from Ligusictum wallichii and 
andrographolides from Andrographis paniculata have been shown to inhibit NO synthesis by 
inhibiting inducible nitric oxide synthase (iNOS) activity (Kondo, Takano and Hojo, 1993; 
Kang, Lee, Lee, Lee, Ryu, Yun-Choi and Chang, 1999; Wu, Liao, Chen and Yen, 1999; 
Chiou, Chen and Lin, 2000; Achike and Kwan, 2003; Wang, Ma, Tao and Lipsky, 2004). Of 
importance to this study was the observation that oleananes, 3,12-dioxoolean-l-en-28-oic acid 
(TP-69) and 3,11-dioxooleanl, 12-dien-28-oic acid (TP-72), derivatives of OA inhibit the 
expression of iNOS (Suh, Honda, Finlay, Barchowsky, Williams, Benoit, Xie, Nathan, 
Gribble and Sporn, 1998).  Plant-derived active compounds like polyphenols which include 
flavonoids, tannins, lignans and catechins have been shown to decrease the formation of NO 
by either direct scavenging of NO or by inhibiting the expression of iNOS (van Acker, Tromp, 
Haenen, van der Vijgh and Bast, 1995; Ryu, Lee, Jeong, Ryu and Han, 1998; Wakabayashi, 
1999; Son, Lee, Yun-Choi and Ryu, 2000; Chi, Cheon and Kim, 2001; Achike and Kwan, 
2003). 
 
Increased Na+ reabsorption is associated with increase in blood pressure and conventional 
drugs used to manage elevated blood pressure include angiotensin converting enzyme 
inhibitors (ACE) and angiotensin II receptor blockers. In addition, extracts from Irvingia 
gabonensi, Sclerocarya birrea (A. Rich.) [Hochst], Ekebergia capensis (Sparrm) [Maliaceae], 
Syzygium cordatum (Hochst.) [Myrtaceae] and Geranium macrorrhizum (Geraniaceae) 
possess blood pressure lowering properties (Miliauskasa and van Beek, 2004; Gondwe, 
Kamadyaapa, Tufts, Chuturgoon and Musabayane, 2008; Kamadyaapa, Gondwe, Moodley, 
Ojewole and Musabayane, 2009;  Mapanga, Tufts, Shode and Musabayane, 2009; Nosiri, 
Hussaini and Abdurahaman, 2011). Furthermore, extracts from Schinus molle (Molle), 
Lepidium meyenii Walp (Maca), Cyclanthera pedata (Caigua), Zingiber officinale (ginger), 
Euphorbia hirta and Lamiaceae species have been shown to have significant ACE inhibitory 
activities (Ivancheva, Manolova, Serkedjeva, Dimov and Ivanovska, 1992; Barbosa-Filho, 
Martins, Rabelo, Moura, Silva, Cunha, Souza, Almeida and Medeiros, 2006; Kwon, Vattem 




proximal tubule which is divided into proximal convoluted and proximal straight tubules. The 
convoluted tubule has cuboidal columnar cells with a brush border of microvilli which has a 
large number of mitochondria for energy production required for active transport of solutes 
(Little, Brennan, Georgas, Davies, Davidson, Baldock, Beverdam, Bertram, Capel and Chiu, 
2007; Yu, Carroll, Rajagopal, Kobayashi, Ren and McMahon, 2009). Therefore, transport 
processes in the straight tubule are highly developed compared to convoluted tubule which 
has fewer microvilli and mitochondria. Reports indicate that approximately 65% of Na+ 
reabsorption occurs in the proximal tubule due to increased surface area attributed by the 
presence of the microvilli where the apical Na+- hydrogen exchanger type 3 (NHE3) and Na+-
phosphate cotransporter 2 (NaPi2) are located (Girardi, Fukuda, Rossoni, Malnic and 
Reboucas, 2008, Lorenz, Schultheis, Traynor, Shull and Schnermann, 1999). Some studies 
indicate that angiotensin-converting enzyme inhibitor, captopril decreases proximal tubule 
Na+ and water reabsorption by causing redistribution of these transporters out of the microvilli 
resulting in natriuresis and diuresis (Leong, Devillez, Sandberg, Yang, Yip, Klein and 
McDonough, 2006; Riquier-Brison, Leong, Pihakaski-Maunsbach and McDonough, 2010).  
 
Extending from the proximal tubule is the thick and thin segments of the loop of Henle which 
have ascending and descending limbs. Cells of the thick limb are cuboidal, but do not have a 
brush border and those of the thin limb are flat and squamous (Prasad et al., 2007). Following 
the loop of Henle is the distal convoluted tubule which joins the collecting ducts. Collecting 
ducts are lined by cuboidal cells which are impermeable to tubular contents and hence 
transport processes in this part of the tubule are influenced by hormones (Schuster, 1993; Yu 
et al., 2009; Arroyo, Ronzaud, Lagnaz, Staub and Gamba, 2011). Understanding the structure 
of the nephron is essential since all the above mentioned segments are structurally adapted to 










Na+ is the major cation that controls osmolality in the extracellular fluid (ECF) volume 
(DeFronzo, Cooke, Andres, Faloona and Davis, 1975) and hence Na+ reabsorption is vital for 
maintenance of homeostasis in the ECF (DeFronzo et al., 2001; Edwards, 2010). Since Na+ is 
present in the highest concentration in the ECF, this cation is filtered and reabsorbed in the 
largest amount in the kidneys.  Reabsorption of water and many other solutes is linked to Na+ 
reabsorption as some substances depend on co-transport with Na+ for their uptake 
(Hackenthal, Paul, Ganten and Taugner, 1990; Klar, Vitzthum and Kurtz, 2004). However, the 
normal ECF osmolality and volume brought about by Na+ reabsorption is disturbed in 
diabetes since the long term effects of this disorder in the kidney results in increased Na+ and 
water retention. Na+ reabsorption consumes a tremendous amount of ATP and oxygen and this 
is why the kidney receives approximately 25% of cardiac output (Lewy, Quintanilla, Levin 
and Kessler, 1973; Ljungman, Laragh and Cody, 1990; Gomez, Warner, Haas, Bolterman, 
Textor, Lerman and Romero, 2009; Hallows, Mount, Pastor-Soler and Power, 2010). Two 
thirds of the filtered Na+ is handled in the proximal tubule through transport processes 
explained below. Proximal tubular Na+ handling can be quantitatively estimated through 
lithium clearance and hence this study employed this technique to establish OA effects on Na+ 
handling in the proximal tubule.  
 
1.2.1. Transport processes in the proximal tubule 
 
The most important process in the proximal tubule is the reabsorption of two thirds of the 
filtered Na+ by an active process using transport proteins like the apical NHE3 and NaPi2 and 
the basolateral Na+- K+ ATPase, (Lorenz et al., 1999; Ganz, Hawkins and Reilly, 2000; 
Aronson, 2002; Girardi et al., 2008; Yingst, Araghi, Doci, Mattingly and Beierwaltes, 2009; 
Auriemma, Galdiero, De Martino, De Leo, Grasso, Vitale, Cozzolino, Lombardi, Colao and 
Pivonello, 2010). Diffusion of Na+ into the proximal tubular cell is favoured by the negative 
intracellular potential and electrochemical gradient in relation to both luminal and peritubular 
fluids (Doucet, Favre and Deschênes, 2007). The entry of Na+ into the tubular cell from the 
lumen occurs via simple diffusion, exchange for H+, co-transport with glucose and chloride 
(Cl-) (Mahnensmith and Aronson, 1985; DeFronzo et al., 2001; Aronson, 2002; Pannabecker 




tubular cells into the lateral intercellular spaces accompanied by Cl- leads to accumulation of 
NaCl in spaces and a local increase in osmotic pressure which causes osmotic entry of water 
into intercellular spaces (Layton, Layton, Dantzler and Pannabecker, 2009).  
 
Na+ reabsorption loosely links the active reabsorption of bicarbonate which also takes place in 
the proximal tubule and is accompanied by active secretion of H+ ions into the tubular lumen 
(DeFronzo et al., 2001; Aronson, 2002; Pannabecker and Dantzler 2006, 2007). Therefore, 
passive Na+ entry into the intracellular space is favoured by both electrical and concentration 
gradients (Aronson, 1982; Funder, Wieth, Jensen and Ibsen, 1984; Mahnensmith and 
Aronson, 1985). Na+ reabsorption is greatly increased in diabetes due to increase function of 
the sodium-glucose cotransporter (SGLT) and the NHE3 in the proximal tubule (Vallon, 
Richter, Blantz, Thomson and Osswald, 1999; Ganz, Hawkins and Reilly, 2000). This is 
accompanied by increased water retention. Diuretics are used to increase fluid excretion 
through inhibition of Na+ transporters thereby causing diuresis and natriuresis. Some plant 
extracts like those from Foeniculum vulgare L. (fennel, Apiaceae) have been shown to 
increase water and sodium excretion (Bardai, Lyoussi, Wibo and More, 2001). The following 
paragraph briefly explains the transport processes that occur in the in the loop of Henle, distal 
tubule and collecting ducts.  
 
1.2.1. Processes in the loop of Henle, distal tubule and collecting ducts 
 
The most important process in the loop of Henle is the countercurrent multiplication system 
which preserves inner medullar interstitial solute gradient (Yuan and Pannabecker, 2010). The 
descending limb of the loop of Henle is highly permeable to water and relatively permeable to 
NaCl. Water extraction increases NaCl concentration in the tubule (Pannabecker, Dantzler, 
Layton and Layton, 2008; Layton et al., 2009). Osmolality of the fluid in the lumen is 
increased by urea which is added to the medullary interstitium from the collecting duct by 
diffusion down a concentration gradient (Layton et al., 2009). The ascending limb actively 
extrudes NaCl into the medullary interstitium through the bumetanide-sensitive cotransporter 
(NKCC2/BSC1) and the NHE3, but is impermeable to water hence the osmolality in the 




(Pannabecker and Dantzler 2006, 2007). NKCC2/BSC1 mediates entry of 1Na+, 2Cl- and lK+ 
into the tubular cell across the luminal membrane in the thick ascending limb (Pannabecker 
and Dantzler 2006, 2007; Pannabecker et al., 2008). Early distal tubule reabsorbs NaCl by a 
Na+/Cl- cotransporter (NCC) and is impermeable to water resulting in dilution of the luminal 
fluid (Arroyo et al., 2010). The Na+ that enters the cell is pumped out across the basolateral 
membrane by the neutral Na+/H+ which cause H+ secretion (Bonventre and Leaf, 1982; 
Giebisch, 1998; Arroyo et al., 2010).   
 
The function of Na+ transporters like NKCC2/BSC1, NHE3, NCC can be inhibited by drugs 
such as furosemide, bumetanide, thiazides, hydrochlorothiazide and bendroflumethiazide; 
potassium sparing, amiloride and carbonic anhydrase inhibitors, acetazolamide. This 
inhibition could be beneficial in diabetes since it results in natriuresis and diuresis. (Martinez-
Maldonado and Cordova, 1990; Kim, 2004). Furthermore, aqueous extracts from the roots of 
Carissa edulis (forssk) vahl (Apocynaceae), Ananas comosus (Linn.) Merr. and Carica 
papaya Linn. (Pawpaw, Melon tree) have been shown to possess diuretic properties 
(Sripanidkulchai, Wongpanich, Laupattarakasem, Suwansaksri and Jirakulsomchok, 2001; 
Nedia, Mekonnena and Urgab, 2004).  Transport processes occurring in the late distal tubules 
and collecting ducts explained above are mostly influenced by hormones.   
 
1.2.1.1. Hormonal influence 
 
Late distal tubules and collecting ducts have principal and intercalated cells (Prasad et al., 
2007). Principal cells play a role in the reabsorption of Na+ which is associated with secretion 
of K+.  Na+ reabsorption is increased by aldosterone, a mineralocorticoid hormone which exert 
its effects through Na+ pumps and transporters (Abdallah, Schrier, Edelstein, Jennings, Wyse 
and Ellison, 2001; Tait, Tait and Coghlan, 2004; Hallows et al., 2010; Arroyo et al., 2010). 
This hormone is synthesised from cholesterol through a series of enzymatic reactions that 
occur in the zona glomerulosa of the adrenal cortex (Payne and Hales, 2004; Connell, 
MacKenzie, Freel, Fraser and Davies, 2008). Principal regulators of aldosterone biosynthesis 
are renin-angiotensin system (RAS), extracellular potassium concentration and 




al., 2008; Arroyo et al., 2010).  
 
The major action of aldosterone on epithelial cells is to regulate the reabsorption of Na+ 
thereby also influencing the transport of water across the membrane (Hackenthal et al., 1990; 
Klar, et al., 2004; Arroyo et al., 2010). Aldosterone-induced reabsorption of Na+ in the distal 
tubule is mediated via Na+/K+-ATPase and amiloride-sensitive epithelial sodium channel 
(ENaC) (Abdallah et al; 2001). Reports indicate that in diabetes there are increased protein 
levels of ENaC subunits (α, β and γ) due to hyperactivation of RAAS mediated by the tubulo-
glomerular feedback mechanism  (Klein, Rash, Sands, Ecelbarger and Tiwari, 2009). The 
mechanism in which aldosterone mediate Na+ reabsorption is through modulating the 
expression of Na+ channels in the plasma membrane or increasing their possibility to open 
(Hackenthal et al., 1990; Ganz et al., 2000; Abdallah et al., 2001; Geering, Beguin, Garty, 
Karlish, Fuzesi, Horisberger and Crambert, 2003; Klar et al., 2004).  
 
Increased Na+ reabsorption stimulates anti-diuretic hormone (ADH) also known as arginine 
vasopress (AVP) which increases water permeability in the luminal membrane (Ecelbarger, 
Kim, Wade and Knepper, 2001; Floyd, Mason, Proudman, German, Marples and Mobasheri, 
2007). The primary AVP receptor that controls water reabsorption is the G protein-coupled 
V2 receptor which, when activated, result in a cascade of events that lead to trafficking of 
aquaporin-2 (AQP2) water channels to the apical membrane (Perucca, Bichet, Bardoux, 
Bouby and Bankir, 2008; Bugaj, Pochynyuk and Stockand, 2009;). In the absence of AVP, the 
principal cells are virtually impermeable to water.  In addition to V2 receptor, AVP has been 
shown to exert a natriuretic effect via V1 receptor in experimental animals (Lote, Thewles and 
Wood, 1989; Musabayane, Forsling and Balment, 1997). 
 
 
Increased Na+ reabsorption in diabetes is is associated with water retention and synthetic drugs 
like aldosterone inhibitors are being used to inhibit this retention by increasing excretion. In 
addition, there are herbal extracts like those of Zea mays, Imperata cylindrica, Plantago major 
and Orthosiphon stamineus, Spergularia purpurea, Rosmarinus officinalis and Centaurium 




retention (Dat, Ham, Khac, Lam, Son, Dau, Grabe, Johansson, Lindgren and Stjernstron, 
1992; Haloui, Louedec, Michel and Lyoussi, 2000; Jouad, Haloui, Rhiouani, El-Hilaly and 
Eddouks, 2001; Jouad, Lacaille-Dubois and Eddouks, 2001a; Jouad, Lacaille-Dubois, Lyoussi 
and Eddouks, 2001b; El-Hilaly, Hmammouchib and Lyoussi, 2003).  
 
 
1.3. Kidney Disease 
 
 
Sustained hyperglycaemia results in kidney dysfunction which ultimately results in ESRD. 
ESRD is responsible for the majority of global morbidity and mortality in diabetes, by 2030 it 
is estimated that more than 2million people will need dialysis or transplantation for kidney 
failure (Van Dijk and Berl, 2004; Atkins, 2005; Stevens, Coresh, Greene and Levey, 2006). 
The risk factors of compromised kidney function include hypertension, cardiovascular 
disease, age of more than 60 years, family history of the disease and diabetes (REF). 
Hyperfiltration results in the activation of the glomerulo-tubular feedback reflex which 
restores normal salt delivery to the juxtaglomerular apparatus (Bank and Aynedjian, 1990;). 
However, this causes increased intra-glomerular pressure which leads to renal hypertrophy 
and eventually to the development of diabetic nephropathy (Vervoort et al., 2005). Agents 
which delay the progression of diabetic nephropathy may prevent this condition by increasing 
Na+ loss in the urine, thereby inhibiting the glomerulo-tubular feedback reflex (Bank and 
Aynedjian, 1990; Nelson, Bennett and Beck, 1996; Tuttle, Bruton, Perusek, Lancaster, Kopp 





1.3.1. Diabetic nephropathy 
 
Diabetic nephropathy is responsible for the morbidity and mortality in diabetes as it is the 
most common cause of ESRD (Nathan, 1993; Cooper, 1998; Atkins, 2005; Vervoort et al., 




therapeutic intervention that has been shown to stop the progress of diabetic nephropathy. 
Hence there is an increase in the prevalence of this condition and this will increase the 
financial health burden in affected countries (Nathan, 1993; The Diabetes Control and 
Complications Trial Research Group, 1993; Atkins, 2005).  Initial symptoms of diabetic 
nephropathy include expansion of glomerular mesangial matrix which causes compression of 
capillaries resulting in decreased surface area for filtration and decreased GFR (Gnudi, 
Viberti, Raij, Rodriguez, Burt, Cortes, Hartley, Thomas, Maestrini and Gruden, 2003; Mason 
and Wahab, 2003; Kumar and Shetty, 2008; Lin and Sun, 2011). Other symptoms of diabetic  
nephropathy include increase in renal collagen and creatinine, albuminuria, proteinuria, 
glomerulosclerosis and interstitial fibrosis (Sharma, McCue and Dunn, 2003; Atkins, 2005; 
Ritz and Dikow, 2006; Brosius, 2008; Mogensen, 2000). Diabetic nephropathy results in 
decreased kidney function which is associated with many complications such as anaemia, 
malnutrition, bone disease, decreased quality of life and hypertension (National Kidney 
Foundation, 2002). Diabetic nephropathy is caused by interaction between metabolic and 
haemodynamic factors altered by hyperglcaemia (Cooper, 1998; Gnudi, Thomas and Viberti, 
2007; Kumar et al., 2008).  
 
1.3.1.1. Metabolic Factors 
 
Kidney pathophysiology in diabetes may be as a result of the effects of excess glucose directly 
on kidney cells or indirectly through pathways activated within the kidney including oxidative 
stress, renal polyol formation and accumulation of advanced glycation end products (AGEs) 
(Dunlop, 2000; Arya et al., 2010).  AGEs cause complications in  disorders like diabetes, 
inflammation, hypoxia and ischemia/reperfusion injury (Bucciarelli, Ananthakrishnan, 
Hwang, Kaneko, Song, Sell, Strauch C, Monnier, Yan, Schmidt and Ramasamy, 2008; Chang, 
Wendt, Qu, Kong, Zou, Schmidt and Yan, 2008; Arya et al., 2010). The effects of AGEs on 
kidney function are explained in detail in the following paragraph. 
 
1.3.1.1.1. Effects of advanced glycation end products (AGEs) on kidney function 
 




between reducing sugars and amine residues found in proteins, lipids and nucleic acids (Arya 
et al., 2010). These early glycosylation products accumulate on proteins and undergo a series 
of in vivo rearrangements to form irreversible and complex compounds which are resistant to 
proteolytic degradation (Arya et al., 2010). AGEs exert their biological effects through 
receptor mediated mechanisms, with receptor for advanced glycation end products (RAGE) 
being the most important (D’Agati, Yan, Ramasamy and Schmidt, 2009; Arya et al., 2010). 
RAGE is a signal transduction receptor which is expressed in podocytes and glomerular 
endothelial cells in the human and murine glomerulus (Wendt, Tanji, Guo, Kislinger, Qu, Lu, 
Bucciarelli, Rong, Moser, Markowitz, Stein, Bierhaus, Liliensiek, Arnold, Nawroth, Stern, 
D’Agati and Schmidt, 2003; Yan, Ramasamy, Bucciarelli, Wendt, Lee, Hudson, Stern, Lalla, 
Yan, Rong, Naka and Schmidt, 2004; D’Agati et al., 2009).  
 
Binding of AGEs to the RAGE receptor activates a number of pathways such as increased 
cytosolic reactive species formation, stimulation of protein kinase C (PKC) and nuclear 
transcription factors such as NF‐kβ, activation and expression of transforming growth factor 
beta (TGF‐β) and vascular endothelial growth factor (VEGF) which are implicated in the 
development of diabetic renal disease (Wendt et al., 2003; Arya et al., 2010). Indeed, 
inhibition of the formation of AGEs has been shown to ameliorate diabetic nephropathy (Arya 
et al., 2010). AGEs formation inhibitors like amino guanidine and pyridoxamine have been 
shown to have reno-protective effects in diabetic animals (Lassila, Seah, Allen, Thallas, 
Thomas, Candido, Burns, Forbs, Calkin, Cooper and Jandeleit-Dahm, 2004; Hartog, Voors, 
Bakker, Smit and van Veldhuisen, 2007). 
 
Various medicinal plant-derived compounds have been shown to prevent diabetic nephropathy 
through inhibition of the AGEs or RAGE formation like resveratrol, the extract from Panax 
quinquefolium (Linnaeus) [Araliaceae], phytoestrogen from Vitis vinifera (Linnaeus) 
[Vitaceae]; curcumin from Curcuma longa (Linnaeus) [Zingiberaceae] and glycosides from 
Stelechocarpus cauliflorus (Annonaceae) (Sheetz and King, 2002; Rahbar and Figarola, 2003; 
Kim, Kang, Yamabe, Nagai and Yokozawa, 2007a; Wirasathiena, Pengsuparpa, Suttisria, 
Uedab, Moriyasub and Kawanishib, 2007). Furthermore, several plants like Persea americana 




[Moraceae] have been shown to possess reno-protective effects through amelioration of 
kidney function (Musabayane, Gondwe, Kamadyaapa, Chuturgoon and Ojewole, 2007; 
Gondwe et al., 2008, 2008). However, the mechanisms through which these plant extracts 
ameliorate kidney function have not been fully evaluated.  Therefore, this study attempted to 
elucidate the mechanism through which plant-derived OA ameliorate kidney function, in part, 
by targeting the proximal tubule since this is where most of Na+ reabsorption occurs. We used 
lithium clearance technique since lithium is regarded as the best available reabsorption marker 
for proximal tubular function (Skøtt, 1994). 
 
Kidney complications in diabetes are not only caused by AGEs, but also by oxidative stress 
that is induced by hyperglycemia which results in increased production of reactive oxygen 
species (ROS). ROS cause peroxidation of cell membrane lipids, oxidation of proteins, renal 
vasoconstriction, DNA damage and excessive deposition of extracellular matrix (ECM) in the 
kidney which cause glomerular mesangial expansion and tubulointerstitial fibrosis (Arya et 
al., 2010). Various plant extracts of Salvia sclarea, Salvia glutinosa, Salvia pratensis, 
Lavandula angustifolia (all Lamiaceae family), Calendula officinalis, Matricaria recutita, 
Echinacea purpurea, Rhaponticum carthamoides (all Asteraceae family), Juglans regia, 
(Juglandaceae), Melilotus officinalis (Fabaceae ), Geranium macrorrhizum (Geraniaceae) and 
Potentilla fruticosa (Rosaceae) have been shown to possess anti-oxidant effects and can 
alleviate symptoms of diabetic nephropathy by scavenging the ROS radicals (Bolshakova, 
Lozovskaya and Sapezhinskii, 1998; Lionis, Faresjo, Skoula, Kapsokefalou and Faresjo, 
1998; Tang and Yuan, 1997; Ohsugi, Fan, Has, Xiong, Tezuka, Komatsu, Namba, Saitoh, 
Tazawa and Kadota, 1999; Lei, Mehta, Berenbaum, Zangerl and Engeseth, 2000; Zupko, 
Hohmann, Redei, Falkay, Janicsak and Mathe, 2001; Miliauskasa and van Beek, 2004). In 
addition, reports suggest that the bioactive compound of interest in this study, OA isolated 
from the glossy privet fruit (Ligustrum lucidum Fructus), hawthorn fruit (Crataegi 
pinnatifidae Fructus), Perilla ocymoides L., mint (Mentha piperita), Glycyrrhiza globora, 
Paeonia lactiflora Pall, Hibiscus sabdariffa L., and Mours alba L. possesses anti-oxidant 
properties (Dinkova-Kostova, Liby, Stephenson, Holtzclaw, Gao, Suh, Williams, Risingsong, 





1.3.1.2. Haemodynamic factors 
 
Haemodynamic changes in diabetic nephropathy are caused by activation of vaso-active 
hormone pathways such as the RAAS and endothelin which result in increased systemic and 
intraglomerular pressure (Hargrove and Wong, 2000). These haemodynamic pathways 
activate intracellular second messengers such as PKC, mitogen‐activated protein (MAP 
kinase), nuclear transcription factors such as NF‐kβ and various growth factors such as the 
prosclerotic cytokine, TGF‐β and VEGF (Haneda, 1997; Arya et al., 2010). Increased 
systemic and intraglomerular pressure decrease resistance in both the afferent and efferent 
arterioles of the glomerulus which results in glomerular hyperperfusion and hyperfiltration 
which are the early signs of diabetic nephropathy (Arya et al., 2010). Factors like NO, 
prostanoids, VEGF, TGF‐β1, and the RAAS are implicated in this abnormal regulation of 
body fluid. These haemodynamic changes increase leakage of albumin from the glomerular 
capillaries, overproduction of mesangial cell matrix, thickening of the glomerular basement 
membrane and injury to podocytes (Arya et al., 2010). Furthermore, these haemodynamic 
changes increase mechanical strain which cause localised release of some cytokines and 
growth factors (Wolf and Ziyadeh, 2007). 
 
OA could be a promising inhibitor for the progression of diabetic nephropathy as it has been 
shown to possess hypoglycaemic properties and hence can prevent the formation of AGEs. 
OA has also been shown to ameliorate kidney function which is an added advantage for a 
potential anti-diabetic agent. This study was designed to investigate the effects of OA on 
proximal tubular Na+ handling to further elucidate the potential of OA in preventing kidney 
complications.  
 
1.3.2. Kidney function and blood pressure 
 
The kidney is responsible for regulation of blood pressure through stimulation of renin and 
aldosterone production (De’Oliviera, Price, Fisher, Allan, McKnight, Williams and 




related to primary aldosteronism as substantial proportion of hypertensive patients were found 
to have elevated ARR (De’Oliviera et al., 1999; Connell et al., 2008). Inappropriate regulation 
of aldosterone accounts for 15% of hypertension cases and contributes to the development of 
cardiovascular damage (Mulatero, Stowasser, Loh, Fardella, Gordon, Mosso, Gomez-
Sanchez, Veglio and Young, 2004; Rossi, Bernini, Caliumi, Desideri, Fabris, Ferri, Ganzaroli, 
Giacchetti, Letizia, Maccario, Mallamaci, Mannelli, Mattarello, Moretti, Palumbo, Parenti, 
Porteri, Semplicini, Rizzoni, Rossi, Boscaro, Pessina and Mantero, 2006; Connell et al., 
2008).  
 
Indirect aldosterone production inhibitors like angiotensin-converting enzyme inhibitors and 
receptor blockers have an impact in declining the progression of chronic kidney disease and 
the risk of ESRD (Navaneethan, Nigwekar, Sehgal and Strippoli, 2009). Reports indicate that 
various medicinal plant extracts like Marrubium vulgare L. (horehound, Lamiaceae) and 
Foeniculum vulgare L. (fennel, Apiaceae) possess hypotensive properties. Additionally, 
herbal remedies from Moringa oleifera, Terminalia superba (Combretaceae), Averrhoa 
carambola L. (Oxalidaceae), Phyllanthus acidus (L.), Tulbhagia violacea (Alliacea), 
Herniaria glabra, Verbesina caracasana and Randia siamensis have been shown to have anti-
hypertensive effects and therefore may alleviate high blood pressure  associated with diabetes 
(Faizi, Siddiqui, Saleem, Aftab, Shaheen and Gilani, 1998; Rhiouani, Settaf, Lyoussi, 
Cherrah, Lacaille-Dubois and Hassar, 1999;  Botta, Carmignani, Volpe, Botta, Corelli and 
Delle Monache, 2003; Khwanchuea, Jansakul, Mulvany, Queiroz and Hostettmann, 2007; 
Mackraj, Ramesar, Singh, Govender, Baijnath, Singh and Gathiram, 2008; Leeya, Mulvany, 
Queiroz, Marston, Hostettmann and Jansakul, 2010; Soncini, Santiago, Orlandi, Moraes, 
Peloso, dos Santos, Alves-da-Silva, Paffaro, Bento and Giusti-Paiva, 2011; Tom, Demougeot, 
Mtopi, Dimo, Djomeni, Bilanda, Girard and Berthelot, 2011). Diabetes is associated with 
hypertension which is discussed briefly below. 
1.3.3. Hypertension 
 
The prevalence of hypertension was thought to be high only in Western countries such as 
North America and Western Europe. However, recent studies have revealed that 




all over the World (Connell et al., 2008). Hypertension is widely reported in rural Africa and 
is the common cause of cardiovascular disorders in the continent, and cardiovascular disorders 
are responsible for the majority of mortality in sub-Saharan Africa (Connell et al., 2008). 
Hypertension can be defined as a condition of having elevated blood pressure and can be 
classified to three different categories. Primary hypertension, also referred to as essential 
hypertension is asymptomatic and therefore most people are not aware that they have this 
condition. The cause of primary hypertension has not yet been identified. However, it is 
believed that the kidney dysfunction plays a major role in development of hypertension. A 
study that was conducted in Okamoto demonstrated that transplantation of the kidney of 
spontaneously hypertensive rats (SHR) into a normotensive rat results in development of 
hypertension (Yen, Yu, Roeder and Willard, 1974; Grisk and Rettig, 2001). Similarly, when 
the kidney of an SHR was replaced with that of a normotensive rat, hypertension was 
observed to cease (Yen et al., 1974; Grisk and Rettig, 2001). Kidney dysfunction may be the 
explanation for the development of secondary hypertension as this type of hypertension is 
caused by underlying conditions (Laragh, 2003). The last type of hypertension is gestational 
hypertension which is observed in pregnant women.  
 
1.4. Management of renal disorders 
 
 Most synthetic drugs for management of renal disorders target the haemodynamic factors that 
alter GFR and also the pathways involved in the development of the diabetic nephropathy. 
The current methods of treating renal disorders include ACE inhibitors (Wing, Reid, Ryan, 
Beilin, Brown, Jennings, Johnston, McNeil, Macdonald, Marley, Morgan and West, 2003). 
Aldosterone antagonists like spironolactone block the action of aldosterone in the distal 
tubules hence result in natriuresis whilst the excretion of K+, H+, NH4+ ions is decreased 
(Nakao, Yoshimura, Morita, Takada, Kayano and Ideura, 2002; Wing et al., 2003; 
Navaneethan et al., 2009). Beta-blockers, alpha1-blockers, alpha2-adrenoceptor agonists and 
calcium channel-blockers also inhibit electrolyte reabsorption which prevents water retention 






Other synthetic drugs used to manage renal disorders are diuretics which stimulate the kidneys 
to excrete extracellular fluid by inhibiting Na+ reabsorption and increasing the urine flow. 
Carbonic anhydrase inhibitors like acetazolamide cause depression of the reabsorption of 
HCO3- in the proximal tubule (Swenson, 1998). However, these drugs also promote K+ 
excretion hence cannot be used as a therapy associated with adrenocortical steroids as these 
patients are susceptible to K+ loss (Brown, Nakamura, Ma, Donnert, Freeman, Vaughan and 
Fogo, 2000). Even though these medications are very effective in treating hormonal and 
physiological factors that cause kidney dysfunction, they have some limitations as each of 
them has various side effects such as systemic acidosis, drowsiness and disturbance of vision 
(Brown et al., 2000). Furthermore, these medications are expensive and therefore are not 
easily accessible especially to the communities from poor socio-economic background, hence 
a renewed interest in the use of medicinal plant products for treatment of a variety of chronic 
disorders.  
 
1.4.1. Traditional (indigenous/folk) medicine 
 
 
Reports indicate that 80% of the world’s population uses herbal medicine for primary health 
care especially in developing countries. Approximately, between 12 and 15 million South 
Africans still use traditional remedies from as many as 700 indigenous plant species (Meyer 
and Afolayan, 1995; Grierson and Afolayan, 1999). Herbal drugs comprise traditional 
medicines which primarily use medicinal plant preparations for therapy. Traditional medicine 
has been used for hundreds of years because of their safety, affordability, efficacy, 
accessibility and lesser side effects (Kamboj, 2000; Ozsoy-Sacan, Karabulut-Bulan, Bolkent 
S, Yanardag and Ozgey, 2004; Gao, Li, Li, Liu, Fan, Liu, Zhao, Li and Han, 2009). Increased 
side effects of synthetic products, lack of curative treatment for several chronic diseases, high 
cost of new drugs and emerging diseases are some of the reasons for renewed public interest 
in alternative medicines (Patwardhan, Warude, Pushpangadan and Bhatt, 2005). Reports 
indicate that medicinal plants possess bioactive compounds which are responsible for many 
therapeutic effects ( Shinawie, Singh and Padmavathi, 2000) and there are a number of 
conventional drugs that originate from plants such as aspirin (from willow bark), digoxin 




(Shinawie, 2002). The plant bioactive compound of interest in this study was a pentacyclic 
triterpenoid isolated from Syzygium aromaticum (Hochst.) [Myrtaceae].   
 
1.4.1.1. Syzygium aromaticum 
 
S. aromaticum belongs to Myrtaceae family and is referred to as a clove tree (Figure 1). S. 
aromaticum is an evergreen tree that grows to a height of 15 to 30 meters tall and is native in 
North Moluccas (Indonesia), but is also grown in India, Jamaica, Brazil, and other tropical 
areas (Agbaje, Adeneye and Daramola, 2009). This plant has opposite; ovate leaves which are 
more than 12.7 centimeters long. When fully grown, its flowers are red and white, bell-
shaped, and grow in terminal clusters. The brown, dried, unopened flower buds are called 
cloves. The dried flower bud is familiarly used in the kitchen and the fruit is a one- or two-
seeded berry (Agbage et al., 2009). The leaves are glabrous, with numerous oil glands on 
lower surface. S. aromaticum contains bioactive chemical compounds such as glycosides, 
tannins, polyphenols, triterpenes and saponins. Syzygium spp-derived OA has been shown to 
possess hypoglycaemic, hypotensive, reno- and cardioprotective effects (Musabayane et al., 
2005; Mapanga et al., 2009; Musabayane et al., 2010; Ngubane, Masola and Musabayane, 
2011) in experimental animals. Table 1 below summarises medicinal plant extracts that have 




















                              









Table 1: Medicinal plants that possess hypoglycaemic and renoprotective properties. 












KD Duncan et al., 1999 
Allium sativum L. 
(garlic) 
(Alliaceae) 
roots extracts of raw 
garlic 
DM, KD Al-Qattan et al., 2008; 
Eidi et al., 2005 
Cassia fistula L. 
(Caesalpiniaceae) 
bark ethanol and 
acetone extracts 








Apiaceae)    
fruits aqueous extract KD El Bardai et al., 2001; 















DM, KD Khayyal et al., 2002; 
Komaki et al., 2003; 
Somova et al., 2003; 
Perrinjaquet-Moccetti et 
al., 2008; El and 






stem-bark ethanolic extract DM, KD Gondwe et al., 2008 
Trigonella 
foenum-graecum 





DM, KD Vats et al., 2002;  
Devi et al., 2003;  
Jelodar et al., 2005 















DM, KD  Ohiri et al., 2003; Orhan 








1.4.1.1.1. Triterpene OA   
 
OA is a pentacyclic triterpenoid that widely exists in plants in the form of a free acid and has 
been isolated from more than 120 plant species (Wang and Jiang, 1992; Liu, 1995). OA has 
therapeutic importance due to its diverse pharmacological properties and lower systemic 
toxicities (Liu, 1995, Liu, 2005; Braga, Ayres-Saraiva, Gattass and Capella, 2007; Patil, 
Jadhav, Singh, Mundada and Patil, 2010). OA is the most abundant compound that is regarded 
as the major constituent of many African plant species used in traditional medicine and 
therefore is easily accessible. Multiple administrations of low doses of this triterpene do not 
cause any abnormalities in the heart, brain, and kidneys (Liu 1995). A study by Mapanga et 
al., (2009) demonstrated that OA possesses kidney ameliorative properties in streptozotocin-
induced diabetic rats.  Hence this study employed the conventional methods explained below 
to further evaluate the effects of OA on the functional status of the kidney. 
 
 
1.5. Conventional methods used to assess kidney functional status 
 
1.5.1. Plasma and urine biomarkers 
 
Kidney biomarkers are used to assess exposure to illness and to detect biological 
abnormalities, but are more often used to diagnose and measure a pathological condition 
(Madero, 2006; Endre and Westhuyzen, 2008; Tesch, 2010; Fassett, Venuthurupalli, Gobe, 
Coombes, Cooper and Hoy, 2011). There are a number of plasma and urine biomarkers that 
can be used to assess the functional status of the kidney and these biomarkers have to fulfill a 
certain criteria in order to be considered reliable. Preferred characteristic of a renal biomarker 
is that it should be measured easily, accurately and reproducibly. A renal marker should 
sensitively indicate renal injury or the kidney response to treatment and should provide useful 
and cost-effective clinical information. A renal marker should identify or differentiate specific 
types of renal injury or kidney disease and be applicable across a variety of populations (race, 
gender and age) (Tesch, 2010; Fassett et al., 2011). Blood urea nitrogen (BUN) and creatinine 




easily using an enzyme/oxidation reaction assay and high performance liquid chromatography 
(HPLC) respectively (Mouton and Holder, 2006; Endre and Westhuyzen, 2008). Creatine 
clearance has been used by several authors to assess renal tubular function as a measure of 
GFR (Bursztyn, Ben-Ishay, Mekler and Raz, 1995; Travlos, Morris, Elwell, Duke, Rosenblum 
and Thompson, 1996; Girchev, Markova, Mikhov and Natcheff, 1998; Bertuzzi, Bensi, 
Mayer, Niebylski, Armario and Gauna, 2003; Gondwe et al., 2008; Al-Ahmad, Rand, 
Manjunath, Konstam, Salem, Levey and Sarnak, 2001; Mapanga et al., 2009). GFR can also 
be estimated using exogenous filtration markers like inulin, iothalamate, 
ethylenediaminetetra-acetic acid (EDTA), diethylene triamine penta-acetic acid and iohexol 
(Rosner and Bolton, 2006; Stevens et al., 2006; Dharnidharka, Kwon and Stevens, 2001). The 
criteria for a good filtration marker requires the marker to be freely filtered, small and not 
bind to plasma proteins, to not be toxic or metabolized and to be present in the filtrate at the 
same concentration as in plasma (Endre and Westhuyzen, 2008). One of the effects of 
hyperglycaemia in diabetes is the expansion of mesangial matrix which causes compression of 
the renal capillaries and this has an effect on GFR. Accordingly, this study used creatinine 
clearance to assess the sub-chronic effects of OA on GFR.  
 
A recently emerged, reliable alternative biomarker of renal function is cystatin-C which can 
be measured by an enzyme-linked immunosorbent assay (ELISA). Cystatin-C is a cysteine 
protease inhibitor that is constantly produced by nucleated cells and released into the blood, 
where it is normally reabsorbed and catabolized by kidney tubules without re-entering the 
blood stream (Curhan, 2005; Madero et al., 2006; Mouton and Holder, 2006; Endre and 
Westhuyzen, 2008, Tesch, 2010). A potential biomarker of renal function in kidney diseases 
that are dependent on hypertension is urine angiotensinogen caused by increased uric acid 
which activates the renin-angiotensin system and can be measured by ELISA (Tesch, 2010). 
Biomarkers of renal oxidative stress are also useful in predicting onset of kidney diseases like 
diabetic nephropathy and these include presence of a DNA guanine product, 8-hydroxy-2-
deoxyguanosine (8-OH-dG), 8-isoprostane, 4-hydroxy-2-nonenal 3-nitrotyrosine peptides 
caused by peroxidation of lipids and can all be measured by ELISA or liquid chromatography 
(Radabaugh, 2008; Tesch, 2010; Fassett et al., 2011). Oxidative stress modifies the AGEs 




the paragraphs above. AGE pentosidine can be detected in both serum and urine using ELISA 
and can be used to evaluate early development of diabetic nephropathy (Tesch, 2010).  
 
Glomerular filtration of albumin caused by injury of podocytes results in microalbuminuria 
which can be measured using ELISA and therefore is also a biomarker for renal damage 
(Tesch, 2010). Severely damaged podocytes can detach from the glomerular basement 
membrane and be detected in the urine sediment (Tesch, 2010; Fassett et al., 2011). Analysis 
of the urine sediment by quantitative polymerase chain reaction (PCR) or ELISA can 
determine mRNA or protein levels of podocyte-specific molecules like nephrin, podocin and 
podocalyxin as markers of podocyte injury (Tesch, 2010). Increased urine sediment levels of 
nephrin and podocin have been detected in patients with diabetic nephropathy and active 
lupus nephritis (Wang, Lai, Lai, Chow, Li and Szeto, 2007; Wang, Lai, Tam, Li, Lai, Chow, 
Li and Szeto, 2007). N-acetyl-beta-D-glucosaminidase is a proximal tubular lysosomal 
enzyme which is released during damage to proximal tubules and increase urine levels are 
detected by enzymatic assays (Tesch, 2010; Fassett et al., 2011). Liver-type fatty acid-binding 
protein (L-FABP) is another marker that is shed by proximal tubular cells in response to 
hypoxia (Tesch, 2010; Fassett et al., 2011). Transforming growth factor-β1 (TGF-β1) and 
connective tissue growth factor are two of the major growth factors that promote renal fibrosis 
and can be measured in urine by ELISA (Tesch, 2010; Fassett et al., 2011). In addition to 
creatinine clearance, the kidney function biomarker of interest in this study was lithium 
clearance which is used to quantify the amount of Na+ output from the proximal tubule. 
 
 
1.5.2. Lithium Clearance 
 
Renal clearance of lithium has been used widely in animal studies and clinical investigations 
as a means of assessing proximal tubular function in the mammalian kidney (Koomans, Boer 
and Dorhout-Mees, 1989; Thomsen, 1990, Walter and Shirley, 1991; Shirley and Walter, 
1993; Boer, Fransen, Shirley, Walter, Boer and Koomans, 1995; Whiting, 1999). Lithium 
clearance measurements are based on the observation that lithium undergoes iso-osmotic 




regarded as the best available marker for proximal tubular reabsorption of Na+ (Thomsen, 
1984; Walter and Shirley, 1991; Skott, 1994, Whiting, 1999).  Consequently, lithium 
clearance techniques can be used in both experimental and clinical studies to assesss 
glomerulo-tubular function and handling of Na+ by the proximal tubule in both health and 
disease (Whiting, 1999). Controversially, recent studies have shown that lithium reabsorption 
also takes place in the distal nephron, however, this was only observed in Na+/K+ deprived 
rats (Shalmi, Jonassen, Thomsen, Kibble, Bie and Christensen, 1998; Thomsen and Shalmi, 
1997; Emamifar, Shalmi, Thomsen and Christensen, 2000). Clearance and micropuncture 
studies in rats have confirmed that distal Li+ reabsorption does not occur if it is used in low 
concentrations (Koomans et al., 1989; Shirley, Walter and Sampson, 1992; Thomsen, 1990; 
Walter and Shirley, 1991; Shirley and Walter, 1993). Hence this study employed lithium 
clearance to investigate the effects of OA on proximal tubular Na+ handling since the effects 
of hyperglycaemia mostly affect this part of the nephron where most of Na+ reabsorption takes 
place. In addition, we evaluated the effects of OA on the functional state of the kidney using 
cell culture methods which test the effects of a drug on the viability and structural intergrity of 
isolated cell lines. 
 
 
1.5.3. Cell Culture tests 
 
Cell culture is a process by which cells are grown under controlled conditions which can be 
easily manipulated and analysed (Li, Bode and Sakai, 2004). Cell culture studies are the 
precursor to whole animal studies and help to determine whether significant cytotoxicity 
exists for the given material (Li et al., 2004). Culture of cell lines is essential for biomedical 
research which include medicine, vaccine development, genetics, HIV testing/treatment, 
reconstructive medicine, basic science, cell biology and drug discovery (Dunham and 
Guthmiller, 2008, Farkas and Tannenbaum, 2005). Therefore, understanding the toxicity of 
drugs and chemicals is essential for progress in the pharmaceutical industry, medical science 
and academic research (Farkas & Tannenbaum, 2005; Naesens, Kuypers and Sarwal, 2009). 
Cytotoxicity assays are widely used by pharmaceutical industries to screen for toxicity of their 




dimethylthiazol-2-yl 2,5diphenyltetrozolium bromide (MTT) assay which monitors 
cytotoxicity by measuring the reducing potential of the cell using a colorimetric reaction 
(Mosmann, 1983). In addition, the study used single cell gel electrophoresis commonly known 
as the comet assay which detects DNA damage in individual cells (Olive, Wlodek, Durand 
and Banath, 1992) to assess whether OA exhibit any toxicity in the kidney and the liver. In 
diabetes, the morphology and function of kidney cells is altered, and therefore this study 
elucidated the potential of OA in alleviating kidney damage. Furthermore, the effects of OA 
on cell viability and structural integrity were evaluated in liver cell lines since the liver is 
responsible for degradation of drugs. 
 
 
1.5.3.1. Hepatocyte-derived human transformed cell line (HepG2) 
 
 
HepG2 cells were derived from the liver tissue with a well differentiated hepatocellular 
carcinoma and are epithelial in morphology (Guillouzo, Corlu, Glaise, Morel and Guguen-
Guillouzo, 2007). When cultured properly, HepG2 cells display strong morphological and 
functional differentiation with a formation of apical and basolateral cell surface domains that 
resemble the bile canalicular and sinusoidal domains respectively in vivo (van IJzendoorn, 
Zegers, Kok and Hoekstra, 1997; van IJzendoorn and Hoekstra, 2000). Because of their high 
degree of morphological and functional differentiation in vitro, HepG2 cells are a suitable 
model to study human liver diseases (Ohgaki, 2010). HepG2 cells and its derivatives are also 
used for studies of liver metabolism, toxicity of xenobiotics, detection of cytoprotective, anti-
genotoxic and cogenotoxic agents, understanding hepatocarcinogenesis and for drug targeting 
studies (van IJzendoorn et al., 1997; van IJzendoorn and Hoekstra, 2000). Of interest in this 
study, HepG2 cells were used to evaluate whether OA does not induce liver cell injury since 








HEK cells are a specific cell line originally derived from primary human embryo kidney cells 
grown in tissue culture (Shaw, Morse, Ararat and Graham, 2002). The current commercially 
available source of HEK cell is from the original transformation by Graham, Smiley, Russell, 
and Nairn in 1977 (Thomas and Smart, 2005). These cells are characterized by properties 
found in early developmental stages of renal cell lines and are widely used for transfection 
studies. However, of interest in this study was to evaluate the effects of OA on the viability 
and structure of these cells since diabetes cause damage to kidney cells. 
 
1.5.3.3. Madin Darby bovine kidney cell line (MDBK) 
The MDBK cell line was derived from a kidney of a normal adult steer in 1957 by S.H. Madin 
and N.B. Darby (Nagama, Michiue and Sakurai, 1996; Haque, Mohamad, Uddin and Saeed, 
2010). This epithelial cell line is used in laboratories around the world for a variety of 
applications in toxin research and growth of attenuated viruses for vaccine production. MDBK 
cells were chosen in this study to detect the cytotoxic effects of OA on their viability and 
proliferation. These cells are from the nephron which is the functional unit of the kidney and 
since diabetes results in injury of kidney epithelial cells, studying the effects of OA on MDBK 
cells can give an indication as to whether this triterpene may/or may not further damage the 
kidney cells when used as treatment for diabetes.  
 
 
1.6. Justification and aim of the present study 
 
Medicinal plants extracts have proven to be a potential alternative to manage diabetes mellitus 
despite the current use of conventional anti-diabetic drugs such as insulin. Of interest in this 
study were the effects of a plant-derived bioactive compound, oleanolic acid (OA), on 
promoters of a decline in renal function.  
 
1.6.1. Objectives 
The overall aim was to study the effects of OA on renal function and proximal tubular Na+ 











                                                               CHAPTER 1 




In recent years, there has been a renewed interest in the use of plant products for the treatment 
of a variety of chronic disorders. One such bioactive plant-derived compound is a pentacyclic 
triterpenoid, oleanolic acid (3ß-hydroxy-olea-12-en-28-oic acid, OA) present in herbs and 
dietary plants. OA possesses a variety of medicinal claims which include anti-inflammatory, 
anti-cancer, anti-stomach ulcer, anti-hyperlipidaemic, anti-hypertensive, cardiotonic, anti-
dysrhythmic, anti-aggregation of blood platelets, hepato-protective and anti-diabetic effects. Of 
interest in our laboratory are the anti-diabetic properties of OA. Diabetes mellitus is 
characterized by hyperglycaemia which compromises kidney function. Reports indicate that the 
majority of morbidity and mortality in diabetes is caused by end stage renal disease (ESRD). 
Therefore, this study investigated the effects of OA proximal tubular Na+ handling. In addition, 
we evaluated the effects of OA in human embryonic kidney (HEK293) and Madin-Darby 
bovine kidney (MDBK) cell lines to establish whether OA has any toxic effects on the kidney. 
Furthermore, we evaluated the effects of OA in hepatocyte-derived human transformed 
(HepG2) cell lines since the liver is responsible for biotransformation of drugs. Chapter 1 
describes the physiology of kidney function, adverse effects of diabetes, particularly on renal 
haemodynamics and kidney cell structure and how drugs can influence these adverse effects, 












1.1.1. Kidney function 
Kidneys play a vital role in maintaining the normal volume and composition of body fluids 






Materials and methods 
2.1. Materials 
 
2.1.1. Drugs and chemicals 
 
Drugs and chemicals were sourced as indicated:  
Dimethyl sulphoxide (DMSO), inactin (5-ethyl-5-(l'-methylpropyl)-2-thiobarbiturate), low and 
normal melting agarose, trizma base (tris), triton X-100, ethidium bromide, 
ethylenediaminetetraacetic acid (EDTA), sodium bicarbonate (NaHCO3), sodium chloride 
(NaCl), potassium chloride (KCl), dipotassium phosphate (K2HPO4), sodium hydroxide (NaOH) 
and N-(2- hydroxyethyl) piperazine-N’-(2-ethanesulfonic acid) (HEPES) were purchased from 
Sigma-Aldrich (St. Louis, Missouri, USA). 
 
Silica gel, ethyl acetate (EA), dichloromethane (DCM), ethanol (C2H5OH), methanol (CH3OH), 
chloroform (CHCl3) and hydrogen peroxide (H2O2) were purchased from Merck (Johannesburg, 
South Africa) and halothane was from Fluorothane® (AstraZeneca Pharmaceuticals, South 
Africa). Creatinine was purchased from BDH biochemicals Ltd (Poole, England). Earle’s 
minimum essential medium (EMEM) was from Gibco BRL (Inchinnan, Scotland), foetal bovine 
serum, penicillin G and streptomycin sulphate were purchased from Whittaker Bioproducts 
(Walkersville, Maryland, USA).  
 
 All chemical reagents were of analytical grade. 
 
 
2.2.        Methods  
2.2.1.     Isolation of oleanolic acid (OA) 
The extraction of OA was performed in Chemistry laboratory at UKZN Pietermaritzburg 
campus. OA was isolated from Syzygium aromaticum [(Linnaeus) Merrill & Perry] [Myrtaceae] 
flower buds using a previously validated standard protocol that has been reported from our 




aromaticum (500 g) were sequentially extracted twice at 24h intervals with 1 L of 
dichloromethane (DCM) and ethyl acetate (720 ml) on each occasion. The resulting filtrate was 
filtered using a 30cm filter paper (Whatman, England). The filtrates were concentrated in vacuo 
60± 10C using a laboratory 4000 efficient rotary evaporator (supplied by Laboratory 
Consumables and Chemical Supplies, South Africa) to obtain DCM soluble (63 g) and ethyl 
acetate soluble (EAS, 85 g). Crude EAS were subjected to further purification since previous 
studies indicated that they contain mixtures of OA/UA and methyl maslinate/methyl corosolate 
(Somova, Nadar, Rammanan and Shode, 2003; Musabayane, Mahlalela, Shode and Ojewole, 
2005). Column chromatography with silica gel was used for fractionation of a portion of EAS 
(10 g) using a step gradient of n-hexane-ethyl acetate increasing ratio from 9:10 – 7:30. Fractions 
collected were monitored and analysed by thin layer chromatography (TLC) on pre-coated 
aluminium plates using Merck Si gel F254. The TLC plate was developed with ethyl 
acetate/hexane (8:2) in a TLC tank. Analysed data collected from fractions was compared with 
authentic OA values. Eluates with similar TLC profiles to OA were combined and subjected to 
further chromatographic purification, a yield of OA was 2.5 – 3.0 g per 10 g EAS extraction. 
Pure OA was obtained by recrystallisation with methanol and its structure was confirmed by 
spectroscopic analysis using 1H and 13C Nuclear Magnetic Resonance (NMR) technique. OA had 
the same physical properties as the OA purchased from Sigma-Aldrich (St. Louis, Missouri, 
USA) and hence isolated OA was used to carry out all the experiments.    
 
2.3. Animal studies 
2.3.1. Ethical consideration 
 
Ethical clearance for animal studies was obtained from the animal ethics committee of the 










Male Sprague-Dawley rats (250-300g body weight) bred and housed in the Biomedical Resource 
Unit (BRU) of University of KwaZulu–Natal were used in this study. The animals were 
maintained under standard laboratory conditions of constant temperature (22±2 °C), CO2 (<5000 
p.p.m), relative humidity (55±5%) and illumination (12 h light/dark cycles). The animals had 
free access to water and standard rat chow (Meadows, Pietermaritzburg, South Africa). All 
experiments were performed according to the University of KwaZulu-Natal Research Ethics 
Committee guidelines for experimental animals. 
  
2.4. Experimental design 
 
The studies were divided into in vivo and in vitro experiments. In vivo studies investigated the 
effects of OA on renal fluid and electrolyte handling assessed in anaesthetized and conscious 
male Sprague-Dawley rats. The effects of OA on Na+ handling in the proximal tubule were 
assessed in anaesthetized animals using lithium clearance. In vitro studies evaluated the effects 
of OA in kidney and liver cell lines to establish whether this triterpene exhibited any toxicity in 
these organs. 
 
2.5. Renal studies 
2.5.1. Anaesthetized animals 
2.5.1.1. Renal clearance studies 
Lithium clearance (CLi) was used as a marker for the output of Na+ from the proximal tubules 
(Thomsen and Shirley, 1997). Male Sprague-Dawley rats were given water with lithium chloride 
(12 mmol/kg dry weight) for 48 h prior to experiment to raise plasma lithium to measurable 
concentrations. The rats were prepared for acute renal clearance studies and mean arterial blood 
pressure using previously validated standard protocol that has been reported from our 
laboratories (Musabayane et al., 2007; Mapanga et al, 2009). Briefly, animals were anaesthetized 
with intraperitoneal injection of 0.11 g/kg of inactin (5-ethyl-5-(l'-methylpropyl)-2- 




jugular vein was cannulated with polyethylene tubing (internal diameter, (i.d.) 0.58 mm; external 
diameter, o.d. 0.96 mm; Portex, Hythe, Kent, UK) to allow intravenous infusion of 0.077M NaCl 
containing 0.013M creatinine at 9 ml/h using Harvard Apparatus Syringe Infusion Pump 22 
(Harvard Apparatus, Holliston, Massachusetts, USA).  The urinary bladder of each rat was 
cannulated via midline abdominal incision with polyethylene tubing (internal diameter, (i.d.) 
0.86 mm; external diameter, o.d. 1.27 mm; Portex, Hythe, Kent, UK) to facilitate timed 
collection of urine samples. Body temperature was maintained by placing a rat in a thermally 
controlled heating table (37±10C).  
 
Following a 3½ h equilibration period, measurements were taken over the 4 h post-equilibration 
period of 1 h control, 1 h 30min treatment and 1 h 30min recovery periods. Control animals were 
continuously infused with 0.077M NaCl containing 0.013 M creatinine at 9 ml/h. In those 
animals in which the effects of OA were studied, OA was added to the infusate at 90 µg/h for 1.5 
h (treatment period), the animals were returned to the infusate alone for the last 1.5 h (recovery 
period). Proximal tubular Na+ handling  was  assessed  by  determination  of  endogenous 
lithium  in plasma and urine and by  fractional  excretion of  lithium and  sodium. For mean 
arterial blood pressure measurements, A heparinized cannula (Portex i.d. 0.58 mm; o.d. 0.96 
mm, Hythe, Kent, UK) was inserted into the left carotid artery for continuous recording of 
arterial blood pressure at 30 min intervals via a pressure transducer (Statham MLT 0380, Ad 
Instruments, Bella Vista NSW, Australia), compatible with PowerLab System ML410/W (Bella 
Vista NSW, Australia). Blood samples (0.3 ml) were taken once per hour for measurements of 
electrolyte and clearance marker concentrations. Plasma and urine samples were stored at 40 C 
until assay of creatinine, urea and electrolytes was performed.  
 
 
2.5.2. Conscious animals 
 
Male Sprague-Dawley rats were divided into four groups of untreated and treated (n = 6) 
animals. Experimental groups were treated with various doses of OA (30, 60 and 120 mg/kg, 
p.o.) twice every third day for 5 weeks by means of a ball-tipped, 18-gauge gavage needle 




Weideman,  Sarangapani,  Hu,  Dixit and Sargent; 2009). These doses were chosen because they 
have been shown to have hypoglycaemic effects in STZ- induced diabetic rats (Musabayane et 
al., 2010). Rats were housed individually in Makrolon polycarbonate metabolic cages 
(Tecniplast, Labotec, South Africa) kept at the BRU. Quantitative measurements of urine volume 
and total urinary outputs of Na+, K+, Cl-, creatinine and urea determined after dosing at 09h00 
were performed using Beckman Coulter (Synchron LX20 Clinical Systems, Fullerton, 
Carlifornia, USA) with reagent kits from Beckman Coulter (Synchron LX20 Clinical Systems, 
Dublin, Ireland). The type of bedding used for rat cages was wood shavings. Food, water 
consumption and body weight were recorded 24 h after dosing at 09h00. Untreated controls 
animals were given de-ionised water (3 ml/kg p.o). Mean arterial blood pressure was monitored 
every 3rd consecutive day for 5 weeks at 09h00 using non-invasive tail cuff method (IITC Model 
31 Computerised Blood Pressure Monitor, Life Sciences, Woodland Hills, California, USA) 
previously described (Musabayane et al., 2007; Mapanga et al., 2009). The unit utilizes IITC 
hardware system employing an automatic scanner pump, sensing cuff and amplifier to measure 
blood pressure in the animals' tail and the results are displayed on the computer screen. The 
equipment was calibrated before each day of mean arterial blood pressure measurements The 
animals were kept warm in an enclosed chamber (IITC Model 303sc Animal Test Chamber, 
IITC Life Sciences, Woodland Hills, California, USA) for 30 minutes at ±30°C before taking 
three blood pressure recordings (Gondwe et al., 2008).  
 
2.5.2.1. Terminal studies 
At the end of a 5 week experimental period, animals were anaesthetized in a 2.3L anaesthetic 
chamber with 2.17 ml/L of halothane (Fluorothane®, Astra Zeneca 2002) pharmaceuticals (Pty) 
LTD for 3 minutes. The chamber relied on atmospheric air for vaposization of the halothane. 
Blood samples were collected from all groups of animals by a terminal cardiac puncture into 
individual pre-cooled heparinized containers 24 h after the last treatment. Blood was centrifuged 
in an eppendorf centrifuge (Fisher Scientific GmbH, Schwerte, Germany) for 15 minutes at 3500 
rpm g x 100 at 4 °C to separate the plasma. Separated plasma was stored in a BioUltra freezer 
(Snijders Scientific, Tilburg, Netherlands) at -70 °C until assayed for Na+, K+, Cl-, creatinine and 








2.6. Laboratory analysis 
 
2.6.1. Biochemical measurements 
 
Urine volume was determined gravimetrically using a balance (Mettler balance PC 180- 
instruments, Protea Laboratory Services, Johannesburg, South Africa). Na+, K+, CI-, urea and 
creatinine concentrations were determined by ion activity using the Beckman Coulter (Synchron 
LX20 Clinical Systems, Fullerton, California, USA). Creatinine estimation employed the 
reaction of creatinine and sodium picrate to form creatinine picrate. Urea estimation employed 
the hydrolytic degradation of urea in the presence of urease. The methods used reagent kits from 
Beckman Coulter, Dublin, Ireland. 
 
 
2.6.2. Lithium measurements 
 
A Perkin Elmer atomic absorption/flame emission spectrometer (Optima 2100 DV, New York, 
Waltham, USA) equipped with Li+ hollow-cathode lamp as a radiation source and air-nitrous 
oxide-acetylene flame with a wavelength of 670.8 nm was used for determination of Li+ 
concentrations in plasma and urine samples. The operating conditions were those recommended 
by the manufacturer. The sample, the acetylene flow rates and the burner height were adjusted in 
order to obtain the maximum absorbance signal while aspirating the analyte solution. Standard 
solutions of Li+ ranging from 0.0004 - 0.0603 mmol/l were prepared from a stock solution of 
0.1152 mmol/l and values of urinary and plasma Li+ were extrapolated from a standard curve. 
 
Technique: Photons of radiation from the analyte emission strike the photosensitive area of the 
detector where photoelectrons are produced in each pixel of the detector. The electrons are 
moved into the register where they accumulate as electric charge for the period selected for the 




the signal processing electronic. The pixels in each vertical row are binned into the register for 
the respective array. This instrument uses a 40-MHz free-running solid state generator to ionize 
the argon in the torch and excite the atoms of the liquid sample so that they emit energy at their 
atomic wavelength in the form of photons. The photons from the torch are detected optically and 
measured electronically in the spectrometer section of the Optima 2100 DV and displayed in 
terms of wavelength and intensity, which are converted to sample concentration (Bilhorn, 
Weedler J.V, Epperson and Denton, 1987; DoL, Knochen and Vieras, 1992, Leyssac and 
Christensen, 1994; Shalmi, Kibble, Day, Christensen and Atherton, 1994; Steinhduslin, Burnier, 
Magnin, Munafo, Buclin, Diezi and Biollaz, 1994; Shalmi et al., 1998; Chen and Teo, 2001; 
Aliasgharpour and Hagani, 2009). 
 
2.6.3. Calculations 
Lithium clearance (CLi) was used as a marker for the output of Na+ from the proximal tubules 
(Thomsen and Shirley, 1997). Renal clearances (C) and fractional excretions (FE) were 
calculated with the standard formulae C = U x V/P and FE = C/GFR, where U is the urinary 
concentration, V is the urine flow rate and P is the plasma concentration. FENa distal was 
calculated as CNa/CLi.  
Glomerular filtration rate (GFR), as assessed by creatinine clearance was calculated at 30 min 
intervals in anaesthetized rats and in the 5th week in conscious animals using the standard 




2.7. Cell culture studies 
The HEK293 cell line was obtained from University of the Witwatersrand, Faculty of Health 
Sciences, MDBK and HepG2 cells were purchased from Highveld Biological (Johannesburg, 
South Africa). Cell lines were initially propagated in 25 cm2  flasks (Bibby-Sterilin, 
Staffordshire, England),   at 37oC in Earle’s minimum essential medium (EMEM) (Gibco BRL, 




NaHCO3, 100 U/ml penicillin G and 100 µg/ml streptomycin sulphate (Whittaker Bioproducts, 
Walkersville, Maryland, USA) at pH 7.5. Cells were divided 1:3 every 3-4 days and stored in a 
biofreezer (-80oC) in complete medium containing 10% dimethyl sulphoxide (DMSO). 
 
2.7.1.   3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 
Cell viability was assessed using the MTT assay originally described by Mosmann (1983).    
Cells were trypsinised and seeded into 48-well plates (Bibby-Sterilin, Staffordshire, England) at 
a seeding density of 1.8 x 104 cells/well and incubated for 24 h to permit attachment and growth 
of cells to semi-confluency. Thereafter, the medium (0.5 mL) was replaced and OA (0, 5, 10, 20, 
40, and 80 µmol/L) was added to the wells and cells incubated at 37ºC for 24, 48 and 72 h 
respectively.  After each incubation period, the medium was removed and MTT solution (5 
mg/ml in phosphate buffered saline, 200 µL) was added to wells. The cells were incubated for 4 
h to allow for the formation of blue formazan crystals. The MTT solution was then replaced with 
DMSO (200 µl/well) and absorbance measured at 570 nm in a UV-visible spectrophotometer 
(Thermoscientific Biomate, Cambridge, UK). The percentage cell viability was then calculated 
as follows: [A570 treated cells – background] / [A570 control cells – background] x 100. 
Technique: Viable cells have active mitochondrial dehydrogenase enzymes which reduce MTT 
dye by cleaving the tetrazolium rings of the pale yellow MTT to form dark blue formazan crystal 
(Bernas and Dobrucki, 2002). These crystals are largely impermeable to cell membranes and 
accumulate within healthy cells. Solubilisation of the cells by the addition of a detergent results 
in the liberation of the crystals which are then solubilised also by the detergent. The number of 
surviving cells is directly proportional to the level of the purple formazan product (Bernas and 
Dobrucki, 2002). This colored solution can be quantified by measuring it’s absorbance at a 
certain wavelength  (between 500 and 600 nm) using a spectrophotometer. When the amount of 
purple formazan produced by cells treated with an agent is compared with the amount of 
formazan produced by untreated cells, the effectiveness of the agent in causing death or changing 
metabolism of cells can be deduced through calculation of percentage cell viability using the 





2.7.2. Single cell gel electrophoresis (comet) assay 
 
DNA damage was evaluated using a previously validated protocol (Singh, McCoy, Tice and 
Schneider, 1988, Tice, Agurell, Anderson, Burlinson, Hartmann, Kobayashi, Miyamae, Rojas, 
Ryu and Sasaki, 2000). Frosted microscope slides were each covered with 400 µl of 1% normal 
melting point agarose in Ca2+ and Mg2+ free Kenny’s solution (0.4M NaCl, 9mM KCl, 0.7mM 
K2HPO4, 2Mm NaHCO3), a coverslip added and the agarose allowed to solidify. The coverslips 
were removed and approximately 1.8 x 104 cells were added to 175 µl of 0.5% low melting point 
agarose in Kenny’s solution. The last layer of 200 µl 1% normal melting point agarose was then 
added. The coverslips were removed, and the slides placed in ice cold, freshly prepared lysis 
buffer (2.5 M NaCI, 100 mM EDTA, 10 mM Tris and 1% Triton X-100 and 10% DMSO, pH 10) 
for 1 h. Thereafter slides were subjected to electrophoresis at 35 min at 25 V (0.83 V/cm) in a 
BioRad horizontal gel electrophoresis unit (BioRad, Richmond, CA, USA) containing chilled 
electrophoresis buffer (300 mM NaOH and 1 mM EDTA, pH 13.5).  Slides were washed with 
three changes of neutralization buffer (0.4 M Tris, pH 7.5), each for 5 min, to remove alkali and 
detergents. Slides were then stained with ethidium bromide (20 µg/ml, 50 µl) a coverslip added 
and analysed. Slides were viewed using an Olympus inverted fluorescent microscope with a 
CC12 fluorescent camera (excitation filter of 450-490 nm and a barrier filter of 520 nm) 
(Wirsam Scientific & Precision Equipment LTD, Johannesburg, South Africa) which allowed for 
computerized image analysis for determination of DNA tails, linearly related to the frequency of 
DNA strand breaks (McKelvey-Martin, Ho, McKeown, Johnston, McCarthy, Rajab and Downes, 
1998). 
Technique: Undamaged DNA is highly organized and is closely associated with matrix proteins 
in the nucleus, however, if it is damaged this organization is interrupted. This causes the compact 
double strands of the DNA to break and single DNA strands move out of the nucleus (Ostling 
and Johanson, 1984; Tice et al., 2000). When exposed in an electric field, undamaged DNA does 
not migrate while the damaged one moves from the anode towards the cathode (Ostling and 
Johanson, 1984; McKelvey-Martin et al., 1998). Therefore, the amount of DNA that leaves the 
nucleus is a measure of the amount of DNA damage in the cell (Singh et al., 1988; Tice et al., 
2000). The image analysis measures the overall intensity of the fluorescence for the migrated and 




the more damage there is present. The overall structure resembles a comet with a circular head 
corresponding to the undamaged DNA that remains in the cavity and a tail of damaged DNA 
(Singh et al., 1988; McKelvey-Martin et al., 1998; Tice et al., 2000). The level of damage is 
determined by the intensity and length of the tail.  
 
2.8. Analysis of data 
 
All data were expressed as means ± S.E.M. Statistical comparisons between treated groups and 
control were performed with GraphPad InStat Software (version 4.00, GraphPad Software, Inc., 
San Diego, California, USA) using one-way analysis of variance (ANOVA) followed by Tukey- 




























This chapter describes the following: 
i. spectroscopic data of OA;  
ii. renal function effects of OA in conscious male Sprague-Dawley rats; 
iii. effects of OA on proximal tubular Na+ handling in anaesthetized animals and 
iv.  in vitro effects of OA in liver and kidney cell lines. 
 
3.1. OA structure 
 
The percentage yield of OA obtained varied from 0.79% to 1.72%. Figure 2 shows 1H-NMR and 
13C-NMR spectra of hydrogen and carbon atoms in the OA molecule. The two carbon signals at 
143.6 and 122.7 ppm correspond to the carbon-carbon olefenic double bond at position 12 and 























Figure 2: Syzygium aromaticum-derived OA 1H (A) and 13C- NMR (B) spectroscopic spectra. 
Pure OA was obtained following recrystallisation of EAS with methanol and elucidated using 1H 












3.2. OA effects on body weight, food and water intake 
 
Table 2 compares the effects of various doses of OA (30, 60, 120 mg/kg, p.o.) on food and water 
intake, and body weight in control and experimental animals over the 5-week period. OA 
administration had no significant influence on food and water intake, and body weight changes 
throughout the experimental period when compared with control animals. 
 
Table 2: Comparison of the effects of OA administration on food and water intake, and body 
weight with control animals. Values are presented as means ± SEM (n=6 in each group).   
 
 Time (weeks) 
Experimental 
protocol 
Parameter 1 2 3 4 5 
Control 30±1 31±1 30±1 29±1 28±1 
OA 30  28±1 27±1 31±1 30±1 31±1 
OA 60  29±1 30±1 29±1 26±3 28±1 
OA 120  27±2 28±1 28±1 28±1 27±1 
 
Food intake  
(g/day) 
     
Control 33±1 31±1 33±1 30±1 28±1 
OA 30  30±1 32±1 32±1 29±1 28±1 
OA 60  32±1 33±1 30±1 29±3 32±1 
OA 120  33±2 28±1 29±1 30±1 29±1 
 
Water intake  
(ml/day) 
     
Control 7±2 13±2 18±2 22±2 24±1 
OA 30  8±1 13±1 19±3 21±3 24±2 
OA 60  6±2 12±2 18±2 20±2 23±1 
OA 120  
% b.wt  
change/week 





3.3. Renal fluid and electrolyte handling 
 
3.3.1. Anaesthetized animals 
 
Figure 3 shows urinary Na+ excretion rate of control and OA-administered animals during the 4 
h experimental period. Na+ excretion rate of control animals which ranged from 711 to756 
µmol/h throughout the experiment compared with the infusion rate of 693 µmol/h. However, OA 
infusion at 90 µg/ h for 1½ h significantly (p < 0.05) increased urinary Na+ outputs from the pre-
treatment value of 713 to 847 µmol/h at the end of the treatment period. OA infusion, however, 
had no influence on urine flow and urinary K+ and Cl- outputs in comparison with control 













Figure 3: Comparison of urinary Na+ excretion (A) rate of control rats with animals administered 
OA. OA was administered for 1½ h during the treatment period. Values are presented as means, 
and vertical bars indicate SEM (n=6 in each group).    p< 0.05 by comparison with control 





Figure 4: Comparison of urine flow (A), K+ (B) and CI- excretion (C) rates of control rats with 
animals administered OA. OA was administered for 1½ h during the treatment period. Values are 




3.3.2. Conscious animals 
 
Figure 5 shows urine flow and urinary Na+ excretion rates of control and OA-administered 
animals during the 5-weeks experimental period. Daily Na+ excretion rate of control animals was 
stable ranging from 210 to 223 mmol/day throughout the experiment. However, administration 
of various doses of OA (30, 60, 120 mg/kg p.o.) significantly (p < 0.05) increased daily Na+ 
output from the 2nd week until the end of the study period in a dose independent manner. OA 
administration, however, had no influence on urine flow and urinary K+ and Cl- outputs (Figure 
6). The OA-evoked increase in Na+ excretion was not reflected in plasma collected at the end of 
the experiment, however, there was a significant (p < 0.05)  decreased in plasma creatinine at the 
end of the experiment (Table 3). OA administration had no influence on plasma K+, Cl-, urea 







Figure 5: Comparison of the effects of various doses of OA administration on 24 h urine flow 
(A) and Na+ excretion (B) rates with control animals. Values are presented as means, and vertical 






Figure 6: Comparison of the effects of various doses of OA administration on urinary K+ (A) and 
CI- excretion (B) rates with control animals. Values are presented as means, and vertical bars 




3.4. Effects of OA on MAP  
 
3.4.1. Anaesthetized animals 
 
MAP of untreated and OA-treated rats over the 4 h experimental period is shown in figure 7. 
Following infusion of hypotonic saline to control rats, no significant variations were seen in the 
MAP throughout the 4-h post-equilibration period. However, intravenous infusion of OA for 1 ½ 
h in the experimental group significantly (p < 0.05) reduced MAP from a pre-treatment value of 
105 to 92 mmHg at the end of the treatment period (n=6). The hypotensive effect of OA did not 
revert back (94 mmHg) to normal during the post-treatment period.  
 
 
Figure 7: Comparison of MAP of control rats with animals administered OA. OA was 
administered for 1½ h during the treatment period. Values are presented as means, and vertical 






3.4.2. Conscious animals  
 
Weekly MAP of control animals ranged from 102 to 104 mmHg throughout the experiment 
(Figure 8). However, administration of various doses of OA (30, 60, 120 mg/kg p.o.) 
significantly (p < 0.05) decreased MAP from the 2nd week until the end of the study period. The 
highest dose of OA (120 mg/kg p.o.) was the most effective in reducing the MAP (from a mean 
value of 103 to 86 mmHg) in weeks 3 and 4 by comparison with lower doses at corresponding 
time periods.  
 
Figure 8: Comparison of the effects of various doses of OA administration on MAP with control 
animals. Values are presented as means, and vertical bars indicate SEM (n=6 in each group).                
p< 0.05 by comparison with control animals at each corresponding time. ♦ p< 0.05 by 






3.5. Effects of OA on GFR  
 
3.5.1. Anaesthetized animals 
 
Following infusion of hypotonic saline to control rats, no significant variations were seen in the 
GFR throughout the 4 h post-equilibration period (Figure 9). However, intravenous infusion of 
OA slightly increased GFR to values that did not achieve statistical significance. 
 
 
Figure 9: Comparison of GFR of control rats with animals administered OA. OA was 
administered for 1½ h during the treatment period. Values are presented as means, and vertical 







3.5.2. Conscious animals  
 
Table 3 shows GFR at the end of the 5-week study period as assessed by creatinine clearance 
(Ccr). Administration of various doses of OA significantly (p < 0.05) reduced plasma creatinine 
concentration of experimental animals with a concomitant increase in GFR.  
  
Table 3: The effects of OA on plasma biochemical parameters in male Sprague-Dawley rats 
which were administered OA twice every third day for five weeks. Values are presented as 
means ±SEM (n=6 in each group). 
 
 Experimental protocol 






Na+ (mmol/l)                                    142±1 141±2         140±2       142±1 
K+ (mmol/l) 4.25±0.25   4.14±0.21 4.03±0.22       4.17±0.20 
Cl- (mmol/l) 104±1 102±1 103±1 101±2 
Urea (mmol/l) 7.5±0.6    8.1±0.3                  8.5±0.5 8.4±0.2 
Creatinine (µmol/l) 27±1 20±3*                         21±2*              20±3*            
GFR (ml/min) 2.58±0.16 3.04±0.16* 3.51±0.17* 3.73±0.17*# 
Kidney weights 
(g/100g b.wt) 
0.43±0.20 0.47±0.06 0.48±0.05 0.47±0.01 
 
* p < 0.05 by comparison with control animals.  









3.6. Renal clearance measurements 
 
Lithium clearance (CLi) was used as a marker for proximal tubular sodium clearance (Thomsen 
and Shirley, 1997). The effect of OA on proximal and distal tubular Na+ clearance was estimated 
by comparing renal lithium clearance (FELi) between anaesthetized control and OA-treated rats. 
The lithium doses used resulted in plasma lithium concentrations between 0.2 and 0.3 mmol/l 
with no difference between the groups. All measured variables during the 4-h experimental 
period were in a steady state and did not differ between the control and the experimental groups 
prior to the infusion of OA. The infusion of OA at 90 µg/ h for 1½ h significantly (p < 0.05) 
increased FELi and FENa proximal/distal by comparison with control animals at the corresponding time 
(Figure 10). However, the FENa distal was slightly reduced by OA treatment to levels that did not 
achieve statistical significance by comparison to FENa proximal at the corresponding time period. In 



















Figure 10: Comparison of FENa proximal and FENa distal (A) and FELi (B) of control rats with animals 
administered OA. OA was administered for 1½ h during the treatment period. Values are 
presented as means, and vertical bars indicate SEM (n=6 in each group).    p< 0.05 by 





3.7. Cell culture studies 
 
In vitro effects of various doses of OA (5, 10, 20, 40, 80 µmol/l) were evaluated in isolated 
hepatocyte-derived human transformed (HepG2), human embryonic kidney (HEK293) and 
Madin-Darby bovine kidney cell lines (MDBK) which were exposed to OA for 24, 48 and 72 h. 
 
3.7.1. Cell viability 
 
Figure 11 shows the percentage cell viability of HepG2, HEK293 and MDBK cell lines. The 
viability and/or metabolic activity of HepG2 cells increased significantly (p < 0.05) after 24 and 
48 h exposure periods when compared to the control. However, the cell viability and/or 
metabolic activity decreased significantly (p < 0.05) after 72 exposure period in comparison to 
24 and 48 h exposure periods but it remained above that of the control. OA treatment 
significantly increased (p < 0.05) the viability and/or metabolic activity of HEK293 and MDBK 
in a dose dependant manner after 24 h exposure in comparison to both the control and the longer 
exposure periods. However, there was a slight decrease in the viability and/or metabolic activity 
of both kidney cell lines after 48 and 72 h exposure which did not reach statistical significance 














Figure 11: The effects of OA on the viability and/or metabolic activity of HepG2 (A), HEK293 
(B) and MDBK (C) cells in vitro after exposure to various concentrations of OA for 24, 48 and 
72 h. Values are presented as means, and vertical bars indicate SEM (n = 6).     p< 0.05 by 





3.7.2. DNA integrity 
 
Figure 12 shows the effects of OA (20 and 80 µmol/l) on the DNA of liver cell lines. Image A 
(24 h) and B (48 h) are control cells which were only suspended in the growth medium and their 
DNA is not damaged. Image C is a positive control treated with hydrogen peroxide (H2O2) which 
caused DNA damage as indicated by the comet tails. Similar to the untreated control, all OA-
treated cells [image D - 24 h, E - 48h, F - 72 h (20 µmol/l) and image G -2 4 h, H - 48 h, I - 72 h 
(80 µmol/l)] had intact DNA. Figure 13 and Figure 14 show the effects of OA on DNA integrity 
of HEK293 and MDBK cell lines, respectively, which were also not influenced by OA exposure 












Figure 12: The effects of OA on DNA integrity of HepG2 cells in vitro after exposure to various 
concentrations of OA for 24, 48 and 72 h. Control for 24 h (A), 48 h (B), H2O2 - 50 µmol/l for 
24h (C), OA - 20 µmol/l for 24 (D), 48h (E) &72h (F), and 80 µmol/l  for 24h (G) 48h (H) & 






Figure 13: The effects of OA on DNA integrity of HEK293 cells in vitro after exposure to 
various concentrations of OA for 24, 48 and 72 h. Control for 24 h (A), 48 h (B) & 72 h (C), OA 







Figure 14: The effects of OA on DNA integrity of MDBK cells in vitro after exposure to various 
concentrations of OA for 24, 48 and 72 h. Control for 24 h (A), 48 h (B) & 72 h (C), OA - 20 














                               
4.0.     General 
 
The aim of the present study was to investigate the effects of plant-derived OA on renal function 
and proximal tubular Na+ handling in an effort to identify the site of action for the previously 
reported OA-evoked increases in urinary Na+ output in male Sprague Dawley rats. This study 
also assessed the effects of OA in kidney and liver cell lines to establish whether this triterpene 
exhibits any toxicity in these organs. The results of the present study, apart from confirming our 
previous observations of the natriuretic effects of OA in rats (Mapanga et al., 2009), indicate that 
this effect is in part mediated via the inhibition of proximal tubular Na+ reabsorption by this 
triterpene. In addition, the results also suggest that OA may have no toxic effects in kidney and 
liver cell lines as indicated by the MTT and comet assays. Taken together with the previous 
observation of the hypoglycaemic effects of OA in streptozotocin-induced diabetic rats, these 
results indicate that OA may be able to prevent or alleviate kidney complications that are 
associated with diabetes. This is clinically relevant considering that the majority of morbidity 
and mortality in diabetes is caused by its microvascular complications including diabetic 
nephropathy (Taskinen, 2000). 
 
The absolute stereostructure of S. aromaticum-derived OA elucidated from the spectra using 1H- 
and 13C-NMR was comparable to the previously reported data (Mahato and Kundu, 1994; 
Mapanga et al., 2009) hence isolated OA was used to carry out all the experiments as it is less 
costly. Renal experimental techniques are well validated as they have been used extensively in 
our laboratory (Musabayane et al., 2007; Mapanga et al., 2009). Renal lithium clearance has 
been used widely in animal studies and clinical investigations as a means of assessing proximal 
tubular function in the mammalian kidney (Thomsen, 1984; Koomans et al., 1989; Thomsen, 
1990; Walter and Shirley, 1991; Shirley and Walter, 1993; Boer et al., 1995; Whiting, 1999). OA 
significantly increased FENa and FELi in anaesthetized animals. Endogenous lithium clearance 
(CLi) was used to estimate changes in proximal tubule Na+ reabsorption. CLi technique for 




proximal tubules to the same degree as Na+. Controversially, recent studies have shown that 
lithium reabsorption also takes place in the distal nephron, however, this was only observed in 
Na+/K+ deprived rats (Shalmi et al., 1998; Thomsen and Shalmi, 1997; Emamifar et al., 2000). 
However, clearance and micropuncture studies in rats have confirmed that distal Li+ reabsorption 
does not occur if it is used in low concentrations (Koomans et al., 1989; Shirley et al., 1992; 
Thomsen, 1990; Walter and Shirley, 1991; Shirley and Walter, 1993). In addition, Leyssac and 
Christensen (1994) have shown that Li+ clearance is a valid, quantitative index of Na+ delivery 
from the proximal tubules if GFR is unchanged. Indeed, Mudaliar et al., (2010) used FeLi to 
assess the mechanisms through which thiazolidinediones (TZDs) treatment for diabetes causes 
fluid retention. They found that TZD-treated individuals had decreased FELi consistent with 
increased Na+ reabsorption (Skott, Vaag and Bruun, 1991; Mudaliar, Chang, Aroda, Chao, 
Burke, Baxi1, Griver, O’Connor and Henry, 2010). Furthermore, Boer et al., (2005) used lithium 
clearance to investigate the long-term changes in renal Na+ handling associated with genetic 
hypertension in spontaneously hypertensive rats (SHR).  They observed that SHR had reduced 
FELi and FENa which suggested an increase in Na+ reabsorption with a concomitant increase in 
blood pressure. However, renal denervation decreased blood pressure and significantly increased 
FELi which indicated an increase in urinary Na+ excretion and a decrease in proximal Na+ 
reabsorption (Boer, Morelli, Figueiredo and Gontijo, 2005). Increased urinary Na+ excretion was 
probably as a result of low aldosterone due to the blunting of the renin-angiotensin-aldosterone 
system (RAAS) in the absence of sympathetic stimulation (Lonn, Yusuf, Jha, Montague, Teo, 
Benedict and Pitt, 1994; Katz, Opsahl, Lunzer, Forbis and Hirsch, 1997).  
 
We suggest that the OA-evoked increases in FENa without any apparent changes in the GFR 
resulted in increase proximal tubular Na+ secretion thereby decreasing reabsorption. 
Accordingly, these results suggest that OA influences transport processes in this portion of the 
nephron. In addition, OA increased FENa in the distal tubule, however to a lesser extent than the 
proximal tubule. These results suggest that OA also influences transport processes in the distal 
tubule and that there is no compensatory increased Na+ reabsorption due to increased Na+ 
delivery to this portion of the nephron. The pronounced increase in urinary Na+ excretion rate 
evoked by OA infusion during the 1½ h in the absence of significant changes in GFR suggests 




Na+ transporters at which OA exerts this Na+ inhibitory action in the proximal and distal tubule 
could not be established by the current observations. Na+ is the major cation that controls 
osmolality in the extracellular fluid (ECF) (DeFronzo et al., 1975). Thus Na+ reabsorption is 
vital for maintenance of ECF volume (DeFronzo et al., 2001; Edwards, 2010). The proximal 
tubule reabsorbs approximately two-thirds of the NaCl that enters the tubular fluid by glomerular 
filtration (Aronson, 1996) mediated by transport proteins (Girardi et al., 2008; Yingst et al., 
2009). The proximal tubular Na+ transporters found in the epithelial cells separate the plasma 
membrane into apical and basolateral membranes (Lorenz et al., 1999). Active Na+ reabsorption 
in the apical membrane is primarily mediated via Na+/H+ exchanger (NHE3) followed by uphill 
active extrusion via basolateral Na+/K+ ATPase (Lorenz et al., 1999; Magyar and McDonough, 
2000). The literature on natriuretic hormones’ actions in the proximal tubule, however, shows 
that transport inhibition is effected via parallel independent inhibition of apical NHE3 and 
basolateral Na+/K+ ATPase (Zhang, Mircheff, Hensley, Magyar, Warnock, Chambrey, Yip, 
Marsh, Holstein-Rathlou and McDonough, 1996). We, therefore, speculate that OA inhibited 
apical NHE3 and basolateral Na+/K+ ATPase in the kidney tubules accounting for increased Na+ 
excretion since NHE3 is a major Na+ transport pathway in the renal proximal tubule (Aronson, 
1996). The results of the current study provide the first in vivo evidence that S. aromaticum-
derived OA possibly increased Na+ secretion in the proximal tubule. However, the precise 
mechanism(s) by which OA leads to impaired proximal tubular Na+ reabsorption remains to be 
elucidated.  
 
In addition to OA increasing urinary Na+ excretion, this triterpene also increased the GFR at the 
end of the 5-week study. GFR is an important marker of kidney function and a correlation 
between increased urinary Na+ excretion and elevation of GFR has been reported in experimental 
animals (Marin-Grez, Fleming and Steinhausen, 1986; Mapanga et al., 2009). GFR was assessed 
by creatinine clearance (Ccr) which has been used in our laboratory and by other authors as a 
fundamental parameter of evaluating renal tubular function (Rebsomen et al., 2006; Kumar et 
al., 2008, Mapanga et al., 2009). A progressive decline in GFR has been reported in diabetes, 
acute renal failure and nephritic syndrome (Kim, Jeon, Lee, Kang, Kook, Ahn, Kim, Cho, Kim, 




Treatment related increases in GFR observed in this study suggest an improvement of kidney 
function in experimental animals.  
 
The results obtained in this study demonstrated that OA-evoked natriuresis is associated with a 
reduction in blood pressure. The hypotensive properties of OA are in line with previous 
observations in Dahl salt sensitive (Somova et al., 2003) and normotensive male Sprague-
Dawley rats (Mapanga et al., 2009). The results are significant considering that long term 
diabetes complications often include elevated blood pressure (Stengel, Billon, van Dijk, Jager, 
Dekker, Simpson and Briggs, 2003). 
 
The MTT and comet assay results showed that OA increase cell viability and does not cause 
DNA damage in kidney cells, respectively. Therefore, the findings of the study suggest that OA-
elicited increase in proximal tubular Na+ secretion was not due to toxicity of this compound but 
may in part be mediated via modulation of cellular activity. Stimulation of cell viability and/or 
metabolism by OA is advantageous to this compound as some plant extracts have been shown to 
decrease the viability of tubular epithelial cells in vitro (Gondwe et al., 2008).  Furthermore, 
extract  of  Aristolochia  fangchi  was  shown  to  induce  cellular  injury  and  apoptosis  in 
proximal  tubular  (LLC‐PK1)  epithelial  cell  lines  and  hence  was  not  a  good  therapeutic 
agent  (Vanhaelen,  Vanhaelen‐  fastre,  But  and  Vanherweghem,  1994;  Lebeau,  Arlt, 
Schmeiser,  Boom,  Verroust,  Devuyst  and  Beauwens,  2001;  Balachandran, Wei,  Lin,  Khan 
and Pasco, 2005; Debelle, Vanherweghem and Nortier, 2008).  
 
In  addition,  this  study  demonstrated  that  OA does not exhibit toxicity in liver  cells. Drug-
induced liver injury is particularly regarded as an alarming public health problem as this organ is 
responsible for biotransformation of drugs (Xu et al., 2008). Some drugs like troglitazone have 
been withdrawn from the market mainly due to hepatotoxicity (The Diabetes Prevention Program 












5.0.   Conclusions     
 
The results described in this study introduce the first in vivo evidence that the previously 
reported OA-evoked increases in urinary Na+ output is in part mediated via increased proximal 
tubular Na+ secretion. In addition, the study shows that OA does not exhibit toxicity in kidney 
and liver cell lines. 
 
5.1. Limitations and directions for future studies. 
 
The limitations of the present study are that the effects of OA on renal active hormones such as 
aldosterone and arginine vasopressin were not established. Therefore, the results for OA effects 
on renal parameters could not be related to the function of these hormones. Future studies should 
therefore investigate the effects of OA on renin-angiotensin ratios, aldosterone and arginine 
vasopressin as these hormones are related to sodium homeostasis. In addition, only one marker 
was used for identification of the site of action of OA. Therefore, future studies should use 
various markers such as diuretics which target other segments of the nephron inorder to fully 
understand the mechanisms elicited by OA in amelioration of kidney function. Furthermore, 
previous studies have indicated increased Na+ reabsorption in the proximal tubule in diabetes 
mellitus, with implications for the Na+-glucose co-transporters, therefore effects of OA on 
sodium transporters may explain the mechanisms for the natriuretic effects observed in this 
study. Toxicity studies were only performed in vitro and therefore future studies will look at the 
histology of renal tissues as well as measurements of blood markers of hepatic function like 
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